Scientific Program

 

Wednesday June 20, 2018: McGill Thompson House 

3650 Mc Tavish St, Montreal, QC H3A 1Y2

19:00 - 22:00

Welcome Reception

 

Thursday June 21, 2018: McGill Faculty Club & Conference Centre

07:00 - 08:00 Continental Breakfast
08:00 - 08:15 Opening Remarks
08:15 - 09:00 Plenary Speaker 1:  Dr. Magnus Ekstrom, Lund University, Sweden
Title:  Epidemiology & Burden of Breathlessness
09:00 - 09:15 Coffee Break
 

Theme 1: Mechanisms of Breathlessness

09:15 - 10:00 Plenary Speaker 2:  Dr. Denis E. O'Donnell, Queen's University, Canada
Title:  Pathophysiological Mechanisms of Breathlessness
10:00 - 10:45 Plenary Speaker 3:  Dr. Kyle Pattinson, University of Oxford, United Kingdom
Title:  Central Mechanisms of Breathlessness
10:45 - 11:05 Speaker:  Dr. Andreas von Leupoldt, University of Leuven, Belgium
Title: Psychological Mechanisms of Breathlessness - A Neural Update About Interactions of Affective States and Traits with Breathlessness
11:05 - 11:15 Oral presentation 1
Speaker:  Dr. Shakeeb H. Moosavi, Oxford Brookes University, United Kingdom
Title: Thalmic deep brain stimulation relieves hypercapnia-induced air hunger
11:15 - 11:25 Oral presentation 2
Speaker:  Michaela Herzog, University of Leuven, Belgium
Title: Seeing others in dyspnea induces vicarious dyspnea in the observer
11:25 - 11:35 Oral presentation 3
Speaker:  Dr. Caroline J. Jolley, Kings College London, United Kingdom
Title:  Neural respiratory drive and symptoms limiting exercise tolerance in COPD
11:35 - 11:45 Oral presentation 4
Speaker:  Dr. Joanna C. Grogono, Oxford Brookes University, United Kingdom
Title: Specificity of dyspnea relief with inhaled furosemide
11:45 - 11:55 Oral presentation 5
Speaker:  Thomas Reijnders, University of Leuven, Belgium
Title: Neural processing of respiratory symptoms in patients with COPD
11:55 - 13:00 LUNCH
 

Theme 2:  Measurement of Breathlessness

13:00 - 13:45 Speakers: Dr. Bob Banzett, Harvard Medical School, USA; Dr. Janelle Yorke, University of Manchester, United Kingdom
Title:  Update on the Multidimensional Evaluation of Breathlessness: Merits of the Multidimensional Dyspnea Profile (MDP) and Dyspnoea-12 (D12)
Moderators:  Dr. Marie Williams, University of South Australia, Australia; Dr. Miriam Johnson, University of Hull, United Kingdom
13:45 - 14:05 Speaker: Dr. Margaret L. Campbell, Wayne State University, USA
Title: Measurement of Breathlessness in the Intensive Care Unit
14:05 - 14:25 Speaker:  Dr. Dennis Jensen, McGill University, Canada
Title: Measurement of Exertional Breathlessness in the Clinical Care Setting of Chronic Pulmonary Disease
14:25 - 14:45 Speaker:  Dr. Bob Banzett, Harvard Medical School, USA
Title: Measurement of Breathlessness by Healthcare Professionals in the Hospital Setting
14:45 - 15:00 Coffee Break
15:00 - 15:45

Lightning Round Presentations:  2 slides in 2 minutes!

  1. Lauren Tracey (McGill University, Canada): Physiological and perceptual responses to exercise according to the locus of symptom limitation in patients with COPD
  2. Dr. Bob Banzett (Harvard Medical School, USA): Variance among and within individuals of air hunger response during constant mechanical ventilation and graded hypercapnia
  3. Amar Mainra (McGill University, Canada):  Physiological mechanisms of exertional breathlessness relief following bariatric surgery for severe obesity
  4. Dr. Nicolle J. Domnik (Queen's University, Canada): Ventilatory control characteristics and dyspnea in mild COPD
  5. Sophie E. Collins (University of Alberta, Canada): Does the carotid chemoreceptor play a role in the potentiated ventilatory and dyspnea response to exercise in chronic heart failure?
  6. Josef Sucec (University of Leuven, Belgium): Can you inhibit behavioral responses while being breathless?
  7. Andrew P. Binks (Virgina Tech Carilion School of Medicine, USA): Tidal volume restrictions and hypercapnia produce indistinguishable forms of dyspnea
  8. Charlotte G. Golding (Oxford Brookes University, United Kingdom): Differential modulation of breathlessness by deep brain stimulation of sub-thalamic and motor thalamic nuclei
  9. Robert Hallowell (Harvard Medical School, USA): Effect of aerosol furosemide (80 mg) on exercise-induced dyspnea in patients
  10. Dr. Joanna C. Grogono (Oxford Brookes University, United Kingdom): Effect of breathing pattern on dyspnea relief with inhaled furosemid in heart failure
  11. Dr. Tony G. Babb (University of Texas Southwester Medical Centre, USA): Multidimensional dyspnea profile in patients referred for cardiopulmonary exercise testing
  12. Norman R. Morris (Griffith University, Australia):  The impact of negative mood on exertional dyspnoea in chronic obstructive pulmonary disease
  13. Joshua Good (University of Ontario Institute of Technology, Canada): Perceptions of dyspnea and functional fitness among community dwelling older adults with obstructive lung disease
  14. Joshua Good (University of Ontario Institute of Technology, Canada):  Correlates of resting and exertional dyspnea in community dwelling older adults with obstructive lung disease
  15. Joshua Good (University of Ontario Institute of Technology, Canada):  Dyspnea during sprint interval and continuous exercise in adults with exercise-induced bronchoconstriction
  16. Abebaw M. Yohannes (Azusa Pacific University, USA): Determinants of dyspnea in COPD patients attending pulmonary rehabilitation program
  17. Carley O'Neill (University of Ontario Institute of Technology, Canada): Perceived dyspnea during high intensity interval exercise and continuous exercise among adults with exercise-induced bronchoconstriction
  18. Carley O'Neill (University of Ontario Institute of Technology, Canada):  The impact of a 6-week high intensity interval exercise intervention on perceived dyspnea among adults with exercise-induced bronchoconstriction
  19. Dr. Alan Hamilton on behalf of Dr. Francois Maltais (Boehringer Ingelheim, Canada): The effect of tiotropium/olodaterol versus tiotropium on breathlessness during the 3-minute constant-speed shuttle walking test in patients with chronic obstructive pulmonary disease. 
15:45 - 17:00 Poster Viewing & Discussion
17:00 - 18:00 Dyspnea Society Business Meeting
19:30 - 22:30 DINNER (Wienstein & Gavino's)
 

Friday June 22, 2018: McGill Faculty Club & Conference Centre

07:00 - 08:00 Continental Breakfast
 

Theme 3:  Management of Breathlessness

08:00 - 08:45 Plenary Speaker 4:  Dr. Sara Booth, University of Cambridge, United Kingdom
Title: Recent Advances in the Pharmacological & Non-Pharmacological Management of Breathlessness
08:45 - 09:30 Plenary Speakers 5 & 6:  Dr. Nick Vozoris, University of Toronto, Canada; Dr. Jean Bourbeau, McGill University, Canada
Title:  Role of Opioids in the Management of Breathlessness - Pro (Bourbeau) vs. Con (Vozoris) Debate
Moderator(s):  TBD
09:30 - 09:45 Coffee Break
09:45 - 09:55 Oral presentation 6
Speaker:  Dr. Jennifer Stevens, Harvard Medical School, USA
Title: Patient mortality, readmissions, and resource use associated with dyspnea among hospitalized patients.
09:55 - 10:05 Oral presentation 7
Speaker: Dr. Janelle Yorke, University of Manchester, United Kingdom
Title: Evaluation of individual activity descriptors of the MRC dyspnoea scale
10:05 - 10:15 Oral presentation 8
Speaker:  Dr. Zainab Ahmadi, Lund University, Sweden
TItle: Is chronic breathlessness less recognized and treated compared with chronic pain?: A case-based randomized controlled trial
10:15 - 10:25 Oral presentation 9
Speaker:  Sara J. Abdallah, McGill University, Canada
Title: Psychological and neural factors influencing variability in response to opioid therapy for breathlessness
10:25 - 10:35 Oral presentation 10
Speaker: Sara J. Abdallah, McGill University, Canada
Title: Is there a role for vaporized cannabis in the management of exertional breathlessness and exercise intolerance in COPD?
10:35 - 11:20

Lightning Round Presentations:  2 slides in 2 minutes!

  1. Kathy M. Baker (Harvard Medical School, USA):  Assessing dyspnea in ICU patients: An opportunity to improve care
  2. Kathy M. Baker (Harvard Medical School, USA):  How we assess for dyspnea: Does "No" mean "Zero"?
  3. Dr. Margaret L. Campbell (Wayne State University, USA):  Mild, moderate, and severe intensity cut-points for the respiratory distress observation scale: A receiver operating characteristics curve analysis
  4. Dr. Margaret L. Campbell (Wayne State University, USA):  Trajectory of dyspnea and respiratory distress among patients in the last month of life
  5. Dr. Jennifer Stevens (Harvard Medical School, USA): Temporal patterns of dyspnea during the hospital stay
  6. Dr. Miriam J. Johnson on behalf of Ann Hutchinson (University of Hull, United Kingdom):  Presentation to the emergency department by breathless patients: A qualitative study
  7. Dr. Magnus Ekstrom on behalf of Dr. David C. Currow (Lund University, Sweden): Missed opportunity? Worsening breathlessness as a harbinger of death: A cohort study
  8. Dr. Miriam J. Johnson on behalf of Ann Hutchinson (University of Hull, United Kingdom): Living with breathlessness: A systematic literature review and thematic synthesis
  9. Emilie Michalovic (McGill University, Canada):  Breathlessness: A major barrier to participation in daily and social activities for adults living with COPD
  10. Emilie Michalovic (McGill University, Canada):  Relief of breathlessness: Top healthcare and research priority for adults living with mild to very severe COPD
  11. Hayley Lewthwaite (University of South Australia, Australia):  Prioritise symptoms, expectations and coping strategies in people with COPD: Delphi consensus of factors important to improve habitual behaviours
  12. Dr. Miriam J. Johnson (University of Hull, United Kingdom):  Breathlessness and sexual activity in older adults: The Australian Longitudinal Study on Ageing
  13. Dr. Marie Williams (University of South Australia, Australia): Pulmonary rehabilitation with and without cognitive behavioral therapy for breathlessness: Pragmatic randomized controlled trial
  14. Dr. Rachael A. Evans (University Hospitals of Leicester NHS Trust, United Kingdom):  Need for integrated symptom-based diagnostic pathways: Results from a pilot diagnostic cardio-respiratory breathlessness clinic
  15. Jacob Sandberg (Lund University, Sweden):  Validation of the Dyspnea Exertion Scale of breathlessness in people with life-limiting illness
  16. Ann Norweg (New York University, USA):  Minimum clinically important difference for the Dyspnea Management Questionnaire-Computer Adaptive Test (DMQ-CAT)
  17. Catherine Paquet (University of South Australia, Australia):  Longitudinal changes in breathlessness assessed with the Dyspnoea-12 and Multidimensional Dyspnea Profile: Sub-analysis of a pragmatic randomised controlled trial
  18. Dr. Joanna C. Grogono (Oxford Brookes University, United Kingdom):  Measuring dyspnea in chronic heart failure
  19. Dr. Alan Hamilton (Boehringer Ingelheim, Canada): Measuring breathlessness during in-clinic exercise testing and everyday activities
  20. Dr. Mathew Cherian (McGill University, Canada): Characteristics of dyspnea among adults with mild to moderate COPD and different exacerbation profiles: inferences from the CanCOLD study
11:20 - 12:35 Poster Viewing & Discussion
12:35 - 13:35 LUNCH
13:35 - 13:55 Speaker:  Dr. Michele Schaeffer, University of British Columbia, Canada
Title: Management of Exertional Breathessness in Interstial Lung Disease: Role of Hyperoxia
13:55 - 14:15 Speaker:  Dr. Caroline Jolley, Kings College London, United Kingdom
Title:  Chronic Breathlessness Service - The UK Experience
14:15 - 14:35 Speaker:  Dr. Cathy Simpson, INSPIRED COPD Outreach Program, Halifax, Canada
Title:  An "INSPIRED" Approach to the Management of Breathlessness in Advanced Chronic Obstructive Pulmonary Disease
14:35 - 14:55 Speaker:  Dr. Marie Williams, University of South Australia, Australia
Title: How do Health Professionals Explain Chronic Breathlessness to their Patients?
14:55 - 15:15 Speaker: Dr. Miriam Johnson, University of Hull, United Kingdom 
Title: Patient and Carer Experience of Breathlessess
15:15 - 15:35 Speaker: Dr. Steffen Simon, University Hospital Cologne, Germany
Title:  Management of Episodic Breathlessness
15:35 - 15:50 Coffee Break
15:50 - 16:50 Roundtable Discussion on Research Priorities on Breathlessness
16:50 - 17:00 Closing Remarks & Acknowledgements